1De Gramont A,Figer A,Seymour M,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18(16):2938.
2Louvet C,Andre T,Tigaud JM,et al.Phase Ⅱ study of oxaliplatin,fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2003,20(23):4543.
2Roth A.D.Curative treatment of gastric cancer:towards a multidisciplinary approach[J].Crit Rev Oncol Hematol,2003,46(1):59-100.
3Wils JA,et al.Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-A step ahead in the treatment of advanced gastric cancer A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group[J].Clin Oncol,1991,9 (5):827-831.
4Webb A,et al.Randomized trial comparing epirubicin,cisplatin,and fluorouracil versus fluorouracil,doxorubicin,and methotrexate in advanced esophagogastric cancer[J].Clin Oncol,1997,15(1):261-267.
5De Vita F,Orditura M,Matano E,et al.A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLFOX-4) as first-line treatment of advanced gastric cancer patients[J].Br J Cancer,2005,92(9):1644-1649.
6Al-Batran SE,Atmaca A,Hegewisch-Becker S,et al.Phase Ⅱ trial of biweekly infusional fluorouracil,folinic acid,and oxaliplatin in patients with advanced gastric cancer[J].Clin Oncol,2004,22(4):658-663.
8Santini D,Graziano F,Catalano V,et al.Weekly oxaliplatin,5-fluorouracil and folinic acid(OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer:results of a phase Ⅱ trial[J].BMC Cancer,2006,10,6:125.
9Douillard JY,Cunningham D,Roth AD,et al.Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer:a multicentre randomised trial[J].Lancet,2000,355:1041-1047.
10Delaunoit T,Goldberg RM,Sargent DJ,et al.Mortality associated with daily bolu5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin:results from Intergroup Trial N9741[J].Cancer,2004,101:2170-2176.
